EmpLiMet XR 25/5/1000mg Tablet is a triple-combination antidiabetic medicine containing Empagliflozin 25mg, Linagliptin 5mg, and Metformin Hydrochloride Extended-Release (XR) 1000mg. It is prescribed for adults with Type 2 diabetes mellitus whose blood sugar is not adequately controlled with diet, exercise, or dual-drug therapy.

The three medicines work through different mechanisms to improve blood glucose control. Empagliflozin helps remove excess glucose through urine, Linagliptin increases insulin release and decreases glucagon levels in a glucose-dependent manner, and Metformin XR reduces glucose production in the liver while improving insulin sensitivity. The extended-release formulation provides convenient once-daily dosing and helps improve treatment adherence.

Uses

• Improves blood sugar control in adults with Type 2 diabetes mellitus.
• Used when dual therapy does not provide adequate glycemic control.
• Helps lower HbA1c and fasting blood glucose levels.
• Used alongside a healthy diet and regular exercise.
• May help reduce the risk of cardiovascular complications in appropriate patients due to the empagliflozin component.

Benefits

• Triple-action blood sugar control in a single tablet.
• Extended-release formulation supports once-daily dosing.
• Helps improve insulin sensitivity.
• Promotes urinary glucose excretion.
• Helps reduce HbA1c levels.
• May provide heart and kidney protective benefits in eligible patients.
• Simplifies diabetes treatment by combining three medicines into one tablet.

Dosage

• Take exactly as prescribed by your healthcare professional.
• Usually taken once daily with food to reduce stomach upset.
• Swallow the tablet whole; do not crush, chew, or split the extended-release tablet.
• Continue following your recommended diet and exercise plan.
• Monitor your blood sugar regularly as advised by your doctor.

Prescription Required: Yes.

How It Works

• Empagliflozin blocks SGLT2 proteins in the kidneys, allowing excess glucose to be eliminated in urine.
• Linagliptin inhibits the DPP-4 enzyme, increasing incretin hormone activity to enhance insulin secretion and reduce glucagon release.
• Metformin XR decreases glucose production by the liver and improves the body's sensitivity to insulin.

Together, these three medicines provide comprehensive blood sugar control through complementary mechanisms.

Common Side Effects

• Nausea
• Diarrhea
• Stomach discomfort
• Increased urination
• Urinary tract infection
• Genital fungal infections
• Headache
• Low blood sugar (mainly when used with insulin or sulfonylureas)
• Dehydration or dizziness

Consult your healthcare provider if side effects persist or become severe.

Do Not Use If

• You have Type 1 diabetes or diabetic ketoacidosis.
• You have severe kidney disease or are on dialysis.
• You are allergic to Empagliflozin, Linagliptin, Metformin, or any of the tablet's ingredients.
• You have a history of lactic acidosis.
• Your doctor advises against its use due to serious liver or kidney impairment.

Storage Instructions

• Store below 30°C in a cool, dry place.
• Protect from heat, moisture, and direct sunlight.
• Keep out of the reach of children.

Price in Pakistan

The price of EmpLiMet XR 25/5/1000mg Tablet generally ranges from Rs. 800 to Rs. 900 per pack of 30 tablets, depending on the pharmacy, manufacturer, and location.

Frequently Asked Questions (FAQs)

What is EmpLiMet XR 25/5/1000mg Tablet used for?

It is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.

How should I take EmpLiMet XR?

Take it once daily with food, exactly as prescribed. Swallow the tablet whole without crushing or chewing.

Can EmpLiMet XR cause low blood sugar?

The risk is generally low when used alone but increases if taken with insulin or sulfonylureas.

Can I stop taking EmpLiMet XR once my blood sugar improves?

No. Continue taking the medicine unless your healthcare provider advises you to stop.

Is EmpLiMet XR a prescription medicine?

Yes. EmpLiMet XR 25/5/1000mg Tablet is a prescription-only medicine and should be used under medical supervision.